News & Updates

Omalizumab scores in the NIH*-sponsored phase III OUtMATCH** trial, increasing the threshold for an allergic reaction to peanut and other common food allergens in children and adults with multiple food allergies.

Children whose mothers have atopic dermatitis (AD) are likely to develop the same disease, while some develop other allergic illness (OAI) first, reports a study. This suggests that not everyone will follow the same sequential pathway.

Singaporeans who have been treated with dupilumab in real-world clinical setting achieve improvements in the signs and symptoms of moderate-to-severe atopic dermatitis, as shown in a retrospective study.